Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

NCT06101277 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT06101277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06101277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2023
Completion date
September 15, 2039
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendiceal cancer, biliary cancer, colorectal cancer, extrahepatic cholangiocarcinoma, gall bladder cancer, intrahepatic cholangiocarcinoma, oligoprogressive, small bowel cancer